Fibroblast Growth Factor 23, Bone Mineral Density, and Risk of Hip Fracture Among Older Adults: The Cardiovascular Health Study

CONTEXT: Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone that also inhibits calcitriol synthesis. OBJECTIVE: Our objective was to evaluate the relationships of plasma FGF23 concentrations with bone mineral density (BMD) and hip fracture in community-dwelling older adults. DESIGN AND SE...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jovanovich, Anna, Bùžková, Petra, Chonchol, Michel, Robbins, John, Fink, Howard A., de Boer, Ian H., Kestenbaum, Bryan, Katz, Ronit, Carbone, Laura, Lee, Jennifer, Laughlin, Gail A., Mukamal, Kenneth J., Fried, Linda F., Shlipak, Michael G., Ix, Joachim H.
Formato: Artigo
Idioma:Inglês
Publicado em: Endocrine Society 2013
Assuntos:
Endocrine Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3733860/
https://ncbi.nlm.nih.gov/pubmed/23771921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2013-1152
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados